In the News

Auburn U, Gen9, Autodesk Collaborate on Synthetic Oncolytic Virus to Treat Cancer in Dogs

  • November 3, 2016

A collaboration between a veterinary oncologist, synthetic DNA manufacturer Gen9, and design software firm Autodesk claims to have created the largest synthetic viral genome to date, which will be used in clinical trials to treat cancer in dogs using oncolytic viruses.

READ MORE

Artificial Cancer-Killing Virus the Longest Yet Synthesized - GEN

  • November 2, 2016

According to a press release issued November 2 by the principals, the synthesis of the sCAV2 virus was accomplished by means of Gen9’s BioFab DNA synthesis platform, which Gen9 describes as an industrialized chip-based technology for gene synthesis. Gen9 asserts that its platform can produce mass quantities of high-quality long-length clonal DNA constructs at prices as low as 3 cents per base pair.

READ MORE

Gen9 Synthesizes Largest Functional Virus for Oncology Research, Joined by Auburn University and Autodesk to Enable Personalized Cancer Treatment

  • November 2, 2016

Gen9’s partnership streak continues. Throughout the year, the gene synthesis company has announced numerous partnerships focused on DNA supply agreements, most notably with companies such as Amyris, which is focused on high-performance renewable products; Ginkgo, which specializes in custom microorganism design; and Arzeda, which seeks to transform chemical production.

READ MORE

GEN Roundup: SynBio Advances on Multiple Fronts

  • June 15, 2016

GEN’s Expert Panelists Discuss Technologies and Products That They Are Developing and Share Their Visions of Where Synbio Is Heading

READ MORE

Ginkgo Bioworks Makes 300 Million Base Pair Deal With Gen9

  • June 8, 2016
Ginkgo Bioworks has just entered an agreement to purchase 300 million base pairs of synthetic DNA from Gen9 . This truly monumental quantity of synthetic DNA is the largest deal that has been struck under Gen9’s recently-launched multiplex axis partnership (MAP) program, as well as a considerable fraction of the world’s total synthetic DNA capacity.
READ MORE

Gen9 and Amyris Strike Synthetic DNA Supply Agreement

  • June 7, 2016

What do you get when you put together a next-generation gene synthesis company and a sustainable growth giant? Considering Gen9’s newest press release, we will know soon enough.

READ MORE

The Next Genetics Moonshot: Building a Human Genome from Scratch - IEEE Spectrum

  • June 2, 2016
Breakthroughs may come from young synthetic biology companies like...Gen9, which mass-produce DNA to their customers’ specifications. Such companies are pushing to bring down costs from today’s price of about 10 cents per “letter” of DNA. (That’s the price if you’re buying a relatively small quantity of DNA; if you’re buying in bulk you might get the price down to about 3 cents per letter.) 
READ MORE

Gen9 Inks Synthetic DNA Supply Deal With Amyris - GenomeWeb

  • June 2, 2016
"A fast, reliable source of high-quality synthetic DNA constructs is an essential component of our microbial engineering platform for the production of high-value molecules," Joel Cherry, president of R&D at Amyris, said in a statement. "With the DNA synthesis throughput and economics that Gen9 offers, we are able to engineer and test new strains more cost effectively, using them to rapidly identify the highest-performing microbes and allowing us to bring sustainable products to market more quickly."
READ MORE

Designer Genes And The DNA To Make Them - Forbes

  • April 28, 2016
I recently heard fascinating and synergistic “innovation stories” from the CEOs of two biotech companies.  One organization,  Arzeda , uses computers to design genes for enzymes and pathways involving multiple enzymes.  The other,  Gen9 , specializes in making long strands of DNA very efficiently and accurately – in this case the DNA that codes for those “designer genes.”  At last week’s BIO World Congress on Industrial Biotechnology , these two companies announced a partnership that exemplifies the astonishing progress that has been made in the field called “synthetic biology.”
READ MORE

Gen9, Arzeda Ink Supply Agreement for Synthetic DNA - GenomeWeb

  • April 22, 2016

NEW YORK (GenomeWeb) – Synthetic DNA fabricator Gen9 and chemical manufacturer Arzeda have announced a supply agreement.

READ MORE